|
A VR-medical-device-training startup a day keeps the FOMO away.
|
Startup of the Year: Daily Dealflow
most promising and innovative startups from around the world.
#DailyDealflow newsletter delivers one seed-stage startup a day, every work day
and is presented by Silicon Valley Bank. |
IMMERTEC
IMMERTEC provides a proprietary, real-time VR software for medical device training and sales.
|
|
The way physicians are trained hasn't changed in over 200 years and has created vast inefficiencies for physicians and medical device companies. Our software allows any physician in the world to instantly connect and train in VR.
|
What Problem Are They Solving?
Although there are seemingly endless applications for our technology, we are presently solving the inefficiencies of the medical device training and sales market. The problems in this market revolve around the costly logistics faced by medical device companies and the challenge of convincing physicians to give up 2-3 days of private practice or personal time to travel and learn a new medical device.
|
What's Innovative About Their Solution?
Our software allows anyone to create real-time, 3D VR content in under 200 milliseconds with our intellectual property doing 100% of the heavy lifting, while others trying to do this type of training in VR utilize massive production teams for even a single production team. Since we don't have to hire these production teams, we can offer a zero capex deal. This means a variable pricing model is possible, as we are selling a computer's time, not a human's. Others charge half up front and half upon completion. As we are an end-to-end solution with software doing the heavy lifting, we can have a training location up and running in a matter of days. Where the production processes behind our competitors can take months to even a year for even a single training program to be created.
|
⚙️ Product Stage
Beta—Private
|
|
🏭 Industries
AR/VR, B2B, Health & Wellness
|
|
|
🤑 Fundraising Status
Actively raising
|
|
💸 Total Funding Range
$500k-$1.5MM
|
|
🙌 Founder Demographics
Veteran, Minority
|
|
|
Traction
We will start a pilot program in Q1 of 2019 with one of the world's largest medical device companies. We seek to leverage this relationship to enter their relevant subsidiaries and branch out to other medical device companies.
|
Big Wins
We are currently entering into a paid pilot in Q1 of 2019 with one of the world's largest medical device companies.
|
Contact the Founder:
Erik Maltais
|
|
The Daily Dealflow is made possible thanks to the support of our amazing partners.
|
Silicon Valley Bank and its extensive team of early stage startup experts are supporters of startup communities everywhere. Click here to learn more. |
|
|
Do you travel for business? American Airlines® has a free, special offer for our friends – companies who enroll in their Business Extra program can earn up to 600 bonus Business Extra points. The program allows your travelers to earn their AAdvantage® miles while collectively earning Business Extra points for the business.
|
|
|
Startup of the Year is powered by Established, a consultancy focused on helping organizations with their innovation, startup, and communication strategies.
Created by the talent responsible for building the Tech.Co brand (acquired by an international publishing company), we're leveraging decades of experience to help our collaborators further (or create) their brand & accomplish their most important goals.
|
|
Established, LLC is not a broker-dealer and cannot provide assurances and makes no representations or warranties as to the timing or price terms for any purchase or sale of early-stage company equity. Nothing contained in this email constitutes investment, legal, tax or other advice. No information or statements contained in this email should be relied upon in making an investment or different decision. You should review all risks and consult all applicable professionals when making any investment decisions. Information and statements contained within this email and any attachments are solely for informational purposes and does not constitute an offer to sell or a solicitation to buy any securities.
|
|
|
|
|
